Psyence Biomedical (PBM) Accumulated Expenses (2023 - 2026)

Psyence Biomedical's Accumulated Expenses history runs 4 years deep, the most recent figure standing at $84684.0 for Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 67.75% year-over-year to $84684.0 in Q1 2026; TTM through Mar 2026 was $84684.0, a 67.75% increase from a year earlier, with the FY2026 full-year figure at $84684.0, up 67.75% from the prior year.
• Accumulated Expenses improved to $84684.0 in Q1 2026 per PBM's latest filing, from $50481.0 in the prior quarter.
• Across five years, Accumulated Expenses topped out at $162557.0 in Q1 2023 and bottomed at $50481.0 in Q1 2025.
• The 4-year median for Accumulated Expenses is $105317.5 (2024), against an average of $105918.2.
• Across the five-year window, Accumulated Expenses plunged 59.92% in 2025 and jumped 67.75% in 2026, its largest moves.
• Year by year, Accumulated Expenses stood at $162557.0 in 2023, then retreated by 22.52% to $125951.0 in 2024, then plunged by 59.92% to $50481.0 in 2025, then soared by 67.75% to $84684.0 in 2026.
• Per Business Quant, the three latest PBM Accumulated Expenses figures stand at $84684.0 (Q1 2026), $50481.0 (Q1 2025), and $125951.0 (Q1 2024).